CanMED: NDC

Drug Name (Brand or Generic) Separate terms with OR to return results that match either term.

Major Class

Package in use from (mm/dd/yyyy):

To:

SEER*Rx Category

Clear All

10,000 Matching Results — Export these results

Click column titles once to sort ascending, and twice to sort descending.

Show Entries

NDC-11 (Package)	NDC-9 (Product)	Generic Name	Brand Name	Strength	SEER*Rx Category	Major Class	Minor Class (Ascending)	Administration Route	Package Effective Date	Package Discontinuation Date	Status
69097-0196-67	69097-0196	Granisetron Hydrochloride	Granisetron Hydrochloride	1.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	June 30, 2008	April 30, 2020	In Use
69097-0197-67	69097-0197	Granisetron Hydrochloride	Granisetron Hydrochloride	4.0 mg/4mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	June 30, 2008	April 30, 2020	In Use
69189-4138-01	69189-4138	Granisetron Hydrochloride	Granisetron Hydrochloride	1.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	March 2, 2015	May 24, 2017	No Longer Used
23155-0168-31	23155-0168	Ondansetron Hydrochloride	Ondansetron Hydrochloride	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	Dec. 13, 2012	Aug. 12, 2020	In Use
23155-0196-31	23155-0196	Ondansetron Hydrochloride	Ondansetron Hydrochloride	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	Jan. 18, 2013		In Use
23155-0196-41	23155-0196	Ondansetron Hydrochloride	Ondansetron Hydrochloride	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	Jan. 18, 2013		In Use
23155-0196-42	23155-0196	Ondansetron Hydrochloride	Ondansetron Hydrochloride	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	Jan. 18, 2013		In Use
23155-0196-43	23155-0196	Ondansetron Hydrochloride	Ondansetron Hydrochloride	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	Jan. 18, 2013	July 31, 2020	In Use
23155-0377-31	23155-0377	Ondansetron Hydrochloride	Ondansetron Hydrochloride	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	Feb. 24, 2014	Oct. 11, 2019	In Use
23155-0378-31	23155-0378	Ondansetron Hydrochloride	Ondansetron Hydrochloride	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	Feb. 19, 2014	Oct. 11, 2019	In Use
23155-0378-41	23155-0378	Ondansetron Hydrochloride	Ondansetron Hydrochloride	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	Feb. 19, 2014	Oct. 11, 2019	In Use
23155-0378-42	23155-0378	Ondansetron Hydrochloride	Ondansetron Hydrochloride	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	Feb. 19, 2014	Oct. 11, 2019	In Use
25021-0782-20	25021-0782	ondansetron hydrochloride	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Aug. 30, 2012	Nov. 30, 2021	No Longer Used
33261-0417-05	33261-0417	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0417-06	33261-0417	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0417-09	33261-0417	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0417-10	33261-0417	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0417-12	33261-0417	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0417-15	33261-0417	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0417-20	33261-0417	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0417-30	33261-0417	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0745-05	33261-0745	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0745-06	33261-0745	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0745-10	33261-0745	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0745-12	33261-0745	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0745-20	33261-0745	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0745-30	33261-0745	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 31, 2007		In Use
33261-0747-01	33261-0747	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 27, 2007		In Use
33358-0498-30	33358-0498	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 26, 2014		In Use
33358-0512-30	33358-0512	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Dec. 2, 2014		In Use
35356-0445-30	35356-0445	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 3, 2011	Dec. 31, 2013	No Longer Used
35356-0652-10	35356-0652	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 3, 2012	June 1, 2016	No Longer Used
35356-0652-20	35356-0652	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 3, 2012	June 1, 2016	No Longer Used
35356-0652-30	35356-0652	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 3, 2012	June 1, 2016	No Longer Used
35356-0679-10	35356-0679	ONDANSETRON HYDROCHLORIDE	ONDANSETRON HYDROCHLORIDE	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	June 30, 2019	In Use
35356-0679-30	35356-0679	ONDANSETRON HYDROCHLORIDE	ONDANSETRON HYDROCHLORIDE	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	June 30, 2019	In Use
35356-0755-65	35356-0755	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 31, 2007	Oct. 11, 2019	In Use
36000-0013-01	36000-0013	Ondansetron Hydrochloride	Ondansetron Hydrochloride	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	March 13, 2013	March 9, 2020	In Use
36000-0014-06	36000-0014	ondansetron hydrochloride and dextrose	Ondansetron hydrochloride and dextrose	32.0 mg/50mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intravenous	April 14, 2009	Feb. 23, 2018	No Longer Used
42254-0077-10	42254-0077	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 2, 2007		In Use
42254-0077-30	42254-0077	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 2, 2007		In Use
42254-0097-10	42254-0097	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 2, 2007		In Use
42254-0212-10	42254-0212	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 27, 2007		In Use
42254-0213-10	42254-0213	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 27, 2007		In Use
43063-0560-02	43063-0560	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 4, 2016	Jan. 18, 2021	No Longer Used
43063-0560-03	43063-0560	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 4, 2016	Jan. 18, 2021	No Longer Used
43063-0560-04	43063-0560	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 4, 2016	Jan. 18, 2021	No Longer Used
43063-0560-05	43063-0560	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Feb. 12, 2015	Jan. 18, 2021	No Longer Used
43063-0560-06	43063-0560	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Feb. 12, 2015	Jan. 18, 2021	No Longer Used
43063-0560-10	43063-0560	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Feb. 12, 2015	Jan. 18, 2021	No Longer Used
43063-0560-20	43063-0560	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Feb. 12, 2015	Jan. 18, 2021	No Longer Used
43063-0592-04	43063-0592	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Dec. 26, 2017	Aug. 9, 2021	In Use
43063-0592-10	43063-0592	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Dec. 4, 2014	Aug. 9, 2021	In Use
50090-1015-00	50090-1015	ondansetron hydrochloride	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 28, 2014	March 31, 2019	In Use
50090-1015-01	50090-1015	ondansetron hydrochloride	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 28, 2014	March 31, 2019	In Use
50090-1015-02	50090-1015	ondansetron hydrochloride	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 28, 2014	March 31, 2019	In Use
50090-1015-03	50090-1015	ondansetron hydrochloride	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 28, 2014	March 31, 2019	In Use
50090-1015-04	50090-1015	ondansetron hydrochloride	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 28, 2014	March 31, 2019	In Use
50090-1128-00	50090-1128	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 28, 2014		In Use
50090-1128-01	50090-1128	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 28, 2014		In Use
50090-1128-02	50090-1128	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 28, 2014		In Use
50090-1600-00	50090-1600	ondansetron hydrochloride	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Jan. 5, 2015	May 31, 2019	In Use
50090-1600-01	50090-1600	ondansetron hydrochloride	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Jan. 5, 2015	Jan. 31, 2018	In Use
50090-1600-02	50090-1600	ondansetron hydrochloride	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Jan. 5, 2015	May 31, 2019	In Use
50090-1600-03	50090-1600	ondansetron hydrochloride	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Jan. 5, 2015	Aug. 31, 2017	In Use
50090-1600-04	50090-1600	ondansetron hydrochloride	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Jan. 5, 2015	May 31, 2019	In Use
50090-1600-05	50090-1600	ondansetron hydrochloride	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Jan. 5, 2015	March 31, 2018	In Use
50090-1659-00	50090-1659	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Jan. 23, 2015		In Use
50090-2103-00	50090-2103	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Oct. 14, 2015	Jan. 31, 2019	In Use
50090-2103-01	50090-2103	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Oct. 14, 2015	Jan. 31, 2019	In Use
50090-2103-02	50090-2103	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Oct. 14, 2015	Jan. 31, 2019	In Use
50090-2104-00	50090-2104	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Oct. 14, 2015	Jan. 31, 2019	In Use
50090-2342-00	50090-2342	Ondansetron	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	April 6, 2016	Sept. 30, 2018	In Use
33261-0761-01	33261-0761	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 27, 2007		In Use
50268-0621-11	50268-0621	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 5, 2016		In Use
50268-0621-15	50268-0621	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 5, 2016		In Use
50268-0622-11	50268-0622	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 5, 2016		In Use
50268-0622-15	50268-0622	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Aug. 5, 2016		In Use
50436-0131-01	50436-0131	Ondansetron Hydrochloride	Ondansetron Hydrochloride	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007		In Use
50436-0132-01	50436-0132	ondansetron hydrochloride	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007		In Use
50436-0132-04	50436-0132	ondansetron hydrochloride	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007		In Use
51079-0524-01	51079-0524	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 9, 2007	Sept. 30, 2019	No Longer Used
51079-0524-20	51079-0524	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 9, 2007	Sept. 30, 2019	No Longer Used
51079-0525-01	51079-0525	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 9, 2007	April 30, 2019	No Longer Used
51079-0525-20	51079-0525	Ondansetron	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	July 9, 2007	April 30, 2019	No Longer Used
51655-0400-43	51655-0400	Ondansetron HCL	Ondansetron HCL	4.0 mg/31	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	March 17, 2014		In Use
51655-0415-04	51655-0415	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 12, 2018		In Use
51655-0415-43	51655-0415	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Dec. 28, 2017		In Use
51655-0415-53	51655-0415	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	April 24, 2018		In Use
51655-0415-54	51655-0415	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Dec. 28, 2017		In Use
51655-0415-55	51655-0415	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Dec. 7, 2017		In Use
51655-0415-87	51655-0415	Ondansetron Hydrochloride	Ondansetron Hydrochloride	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Oct. 24, 2018		In Use
51655-0800-04	51655-0800	ONDANSETRON HYDROCHLORIDE	ONDANSETRON HYDROCHLORIDE	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Dec. 30, 2014		In Use
51655-0803-27	51655-0803	ondansetron hydrochloride	Ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Feb. 23, 2015		In Use
51662-1246-04	51662-1246	ONDANSETRON	ONDANSETRON	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Nov. 19, 2018		In Use
53217-0360-01	53217-0360	ondansetron	ondansetron	8.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	Jan. 18, 2018		In Use
53217-0382-10	53217-0382	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 15, 2018		In Use
55154-0328-08	55154-0328	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	July 31, 2017	No Longer Used
55154-0328-09	55154-0328	Ondansetron	Ondansetron	4.0 mg/1	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Oral	June 25, 2007	Dec. 15, 2015	No Longer Used
55154-2873-05	55154-2873	Ondansetron Hydrochloride	Ondansetron	2.0 mg/mL	Ancillary Therapy	Antiemetic	5HT3 Receptor Antagonist	Intramuscular, Intravenous	Nov. 19, 2010	March 28, 2018	No Longer Used

Found 10,000 results in 6 milliseconds — Export these results

CanMED and the Oncology Toolbox

CanMED: NDC